October Research Symposium to Present the Latest on the Microbiome, Immune System and Celiac Disease Research News to Viewers Around the World
Celiac disease and other autoimmune disease sufferers around the world can learn the latest developments in research and treatment by tuning in to a live webcast of the Second Annual Beyond Celiac Research Symposium, Wednesday, Oct. 10, 2018, 6:00-7:30 p.m.
Leading celiac disease experts will explore the headline-making topic of the role of the immune system – the body’s defense mechanism – in celiac disease, the groundbreaking research into the gut microbiome, and breakthroughs in clinical trials. These experts will also answer questions submitted in advance from webcast viewers and live from the audience.
Worldwide, approximately one in 100 people — about one percent — have celiac disease, a serious genetic autoimmune disease that damages the small intestine when gluten is ingested. Beyond Celiac reports that 83% of Americans with celiac disease are undiagnosed or misdiagnosed with other conditions. Additionally, it’s estimated that 50 million Americans are living with autoimmune disease. Currently no pharmaceutical treatments or cures for celiac disease exist, but ongoing research has the potential to unlock the mystery of celiac disease and autoimmune diseases in general.
The Beyond Celiac Research Symposium panel includes:
- Marie Robert, MD, Chief Scientific Officer at Beyond Celiac and Professor of Pathology and Medicine at Yale School of Medicine. Dr. Robert is a nationally recognized gastrointestinal surgical pathologist, a celiac disease researcher, and has served as the director of Yale’s Program in Gastrointestinal Pathology and the Yale Fellowship in Gastrointestinal Pathology.
- Ciaran Kelly, MD, Professor of Medicine at Harvard Medical School and Director of Gastroenterology Training at Beth Israel Deaconess Medical Center. He is an internationally recognized expert in the diagnosis and management of celiac disease and a member of the Beyond Celiac Board of Directors.
- Maureen M. Leonard, MD, MMSc, Clinical Director of the Center for Celiac Research and Treatment at MassGeneral Hospital for Children and Instructor of Pediatrics at Harvard Medical School. She is part of a groundbreaking study of how the microbiomes of infants who have relatives with celiac disease contribute to celiac disease development.
- Stephen D Miller, PhD, internationally recognized researcher on pathogenesis and regulation of autoimmune disease, and Professor of Microbiology-Immunology at Northwestern University’s Feinberg School of Medicine. His research into nanoparticles engineered for immune regulation are on the leading edge of innovations for the future of celiac disease management.
The webcast is free, but registration is required. Visit www.BeyondCeliac.org/symposium to register.